Connect with us

Medical Research

CBD Pioneer Medical Marijuana Inc. Records Over 30% Hike in the Sales Thanks to Kannaway MLM



CBD Pioneer Medical Marijuana Inc. Records Over 30% Hike in the Sales Thanks to Kannaway MLM
- Ad -

One of the early players in the hemp/CBD supplement field, Medical Marijuana Inc. has announced that the sales have incremented to 30%, highest of all times and now aims to develop products based on additional Cannabinoids.

The company has reported $20.7 million in revenue for the second quarter of 2019 in its most recent earnings statement, a 30.4% hike from the same period a year ago. Most of its sales of its company’s consumer products were made through its network marketing subsidiary Kannaway.

Kannaway made its inceptive appearance this year on Direct Selling News Global 100 list of the biggest MLMs or Multi-level Marketing. In DSN’s most recent list published in April, Kannaway was listed in a tie for 100th place with a projected $60 million in annual revenue over the past 12 months.

Medical Marijuana Inc. reported profits on its products as high as 70%, in its direct selling space. But also like other MLMs, driven mostly by commissions paid to sales associates, sales and marketing expenses were high too, topping 50%.

MMI in an earnings call with analysts, have also discussed works it has done for bringing more manufacturing capabilities in the house to secure its supply chain. Chief operating officer of MMI, Blake Schroeder said

“We find the strengthened Medical Marijuana Inc.’s vertical integration efforts and ownerships of our supply chain, by adding a greater level of processing and refinement at our newly expanded warehouse and manufacturing facility in Utah. We are investing in engineering and equipment that will allow us to control various sites of production of our products that we could not previously, while enabling us to further innovate our product lines.”

The revenue will approach $85 million for the full year, said the company.

CEO of MMI, Stuart Titus said the company has firm belief in CBD and its medicinal aspects. There are many Cannabinoids within the plant yet to explore.

“In addition to our decade worth of research and development into the potential wellness benefits of CBD, one of the Medical Marijuana Inc.’s major investment companies AXIM Biotech have been researching and developing several Cannabigerols, CBG products.”

CBG like CBD is a non-psychoactive Cannabinoids. It’s basically the first Cannabinoids the cannabis plant develops, also called stem cells, which certainly have tremendous medical benefits from anti-inflammatory to potential T-cell mediator and also digestive disturbances.

TC Farrand lives in the hemp haven state Colorado and is a writer who quite literally loves to write. Boasting nearly 20 years of experience as an educational and professional content creator, with a vast array of topics and interests in many subjects, TC’s CBD-related research skills are truly superior. By taking the utmost pride in researching medical literature to enhance his own knowledge, his cannabis insights are very welcomed and happy to have his works on full display here at TOC.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.